Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of using an anti-epidermal growth factor receptor (EGFR) activatable antibody to detect the presence or absence of a cleaving agent and EGFR

Method of using an anti-epidermal growth factor receptor (EGFR) activatable antibody to detect the presence or absence of a cleaving agent and EGFR

US Patent 12139543 · Granted Nov 12, 2024

Estimated economic value: $2,257,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Activatable antibodies that bind epidermal growth factor receptor and methods of2025
Activatable antibodies that bind epidermal growth factor receptor and methods of2025
Methods of qualitatively and/or quantitatively analyzing properties of activatab2025
Compositions and methods for conjugating activatable antibodies2024
Compositions and methods for conjugating activatable antibodies2024
Activatable antibodies that bind epidermal growth factor receptor and methods th2024
Activatable antibodies that bind epidermal growth factor receptor and methods th2024
Activatable antibodies that bind epidermal growth factor receptor and methods th2024
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use the2023
Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use there2022
Anti-CD166 antibodies and uses thereof2022
Method of treating or delaying progression of an epidermal growth factor recepto2021